Dabur India Limited — FDA Class II (D-0637-2026)

Dabur India Limited is recalling 1,185 tubes of a drug due to CGMP deviations. This recall is classified as a safety issue. The recall affects products distributed in the U.S.

• •Dabur India Limited is recalling 1,185 tubes of a drug.
• •The recall is due to CGMP deviations.
• •This is classified as a Class II recall.
• •Consumers should check their medicine cabinets for the recalled product.
• •Recalls like this can indicate potential safety risks.

Consumers who purchased this drug should stop using it and return it to the store. The recall affects 1,185 tubes, indicating a potential safety risk.